Nuformix plc (NFX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.296x

Based on the latest financial reports, Nuformix plc (NFX) has a cash flow conversion efficiency ratio of -0.296x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-223.56K ≈ $-27.20 USD) by net assets (GBX754.93K ≈ $91.85 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nuformix plc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nuformix plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Nuformix plc for a breakdown of total debt and financial obligations.

Nuformix plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nuformix plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AETHER CATALYST SOLUT. F:2QZ	N/A
MSP Recovery Inc NASDAQ:MSPR	-0.004x
Macau Property Opportunities Fund Ltd LSE:MPO	-0.003x
DongBang Medical KQ:240550	N/A
Oneiro Energy PLC LSE:ONE	N/A
Athelney Trust plc LSE:ATY	0.006x
Aditxt Inc. NASDAQ:ADTX	0.265x
S&W Seed Company NASDAQ:SANW	-0.159x

Annual Cash Flow Conversion Efficiency for Nuformix plc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nuformix plc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Nuformix plc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	GBX754.93K ≈ $91.85	GBX-614.61K ≈ $-74.78	-0.814x	-75.53%
2024-09-30	GBX715.57K ≈ $87.06	GBX-331.88K ≈ $-40.38	-0.464x	-256.20%
2023-09-30	GBX4.20 Million ≈ $510.41	GBX-546.23K ≈ $-66.46	-0.130x	-27.12%
2023-03-31	GBX4.23 Million ≈ $514.45	GBX-433.10K ≈ $-52.70	-0.102x	+63.94%
2022-03-31	GBX4.74 Million ≈ $576.47	GBX-1.35 Million ≈ $-163.73	-0.284x	-90.40%
2021-03-31	GBX5.69 Million ≈ $691.85	GBX-848.22K ≈ $-103.20	-0.149x	+2.77%
2020-03-31	GBX4.74 Million ≈ $577.03	GBX-727.60K ≈ $-88.53	-0.153x	-95.54%
2019-03-31	GBX3.82 Million ≈ $464.22	GBX-299.34K ≈ $-36.42	-0.078x	+76.98%
2018-03-31	GBX4.49 Million ≈ $546.69	GBX-1.53 Million ≈ $-186.31	-0.341x	-112.33%
2017-03-31	GBX-179.59K ≈ $-21.85	GBX-496.32K ≈ $-60.39	2.764x	+496.03%
2016-03-31	GBX502.34K ≈ $61.12	GBX-350.55K ≈ $-42.65	-0.698x	-89021.82%
2015-07-31	GBX-110.86K ≈ $-13.49	GBX86.80 ≈ $0.01	-0.001x	-224.10%
2014-07-31	GBX247.00K ≈ $30.05	GBX155.85 ≈ $0.02	0.001x	--

About Nuformix plc

LSE:NFX UK Biotechnology

Market Cap

$43.64K

GBX358.66 Million GBX

Market Cap Rank

#31143 Global

#1213 in UK

Share Price

GBX0.17

Change (1 day)

+0.00%

52-Week Range

GBX0.08 - GBX0.49

All Time High

GBX13.75